Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

NEU1

The protein encoded by this gene is a lysosomal enzyme that cleaves terminal sialic acid residues from substrates such as glycoproteins and glycolipids. In the lysosome, this enzyme is part of a heterotrimeric complex together with beta-galactosidase and cathepsin A (the latter is also referred to as 'protective protein'). Mutations in this gene can lead to sialidosis, a lysosomal storage disease that can be type 1 (cherry red spot-myoclonus syndrome or normosomatic type), which is late-onset, or type 2 (the dysmorphic type), which occurs at an earlier age with increased severity. [provided by RefSeq, Jul 2008]
Full Name
Neuraminidase 1
Function
Catalyzes the removal of sialic acid (N-acetylneuraminic acid) moieties from glycoproteins and glycolipids. To be active, it is strictly dependent on its presence in the multienzyme complex. Appears to have a preference for alpha 2-3 and alpha 2-6 sialyl linkage.
Biological Process
Ganglioside catabolic process Source: GO_Central
Oligosaccharide catabolic process Source: UniProtKB
Cellular Location
Lysosome
Lysosome membrane
Lysosome lumen
Plasma membrane
Cell membrane
Other locations
Cytoplasmic vesicle
Note: Localized not only on the inner side of the lysosomal membrane and in the lysosomal lumen, but also on the plasma membrane and in intracellular vesicles.
Involvement in disease
Sialidosis (SIALIDOSIS):
Lysosomal storage disease occurring as two types with various manifestations. Type 1 sialidosis (cherry red spot-myoclonus syndrome or normosomatic type) is late-onset and it is characterized by the formation of cherry red macular spots in childhood, progressive debilitating myoclonus, insiduous visual loss and rarely ataxia. The diagnosis can be confirmed by the screening of the urine for sialyloligosaccharides. Type 2 sialidosis (also known as dysmorphic type) occurs as several variants of increasing severity with earlier age of onset. It is characterized by the presence of abnormal somatic features including coarse facies and dysostosis multiplex, vertebral deformities, mental retardation, cherry-red spot/myoclonus, sialuria, cytoplasmic vacuolation of peripheral lymphocytes, bone marrow cells and conjunctival epithelial cells.
PTM
N-glycosylated.
Phosphorylation of tyrosine within the internalization signal results in inhibition of sialidase internalization and blockage on the plasma membrane.

Anti-NEU1 antibodies

+ Filters
Loading...
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
Target: NEU1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: A1329
Application*: ICC, IHC, IP, WB
Target: NEU1
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBWJN-1338
Application*: WB, F
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 3D4
Application*: WB, IH
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 3C4
Application*: WB
Target: NEU1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 3B8
Application*: WB
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 3B3
Application*: WB, IH
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBWJN-0108
Application*: IP, WB
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: CBWJN-1337
Application*: WB, IC, P, IH-F, E, IP, IF, F
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 3F9
Application*: E, WB
Target: NEU1
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBWJN-0979
Application*: WB, IP
More Infomation
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Online Inquiry